NetraMark Holdings Inc.

About NetraMark Holdings Inc.

NetraMark is a company focused on empowering clinical trial development teams with AI solutions. Their mission is to revolutionize clinical trials by providing causal insights through Attractor AI, enabling smarter patient-centric protocols, improved trial efficiency, and better decision-making for treatment efficacy, toxicity, and placebo response.

Products & Services

NetraAI:Decodes complexities of patient populations, offering insights to enhance clinical trial efficiency using Attractor-based technology to identify unique patient characteristics.

NetraPlacebo:Identifies patients eliciting placebo responses and reasons behind them, using attitudinal, psychological, and past trial data to optimize trial enrichment and inclusion/exclusion criteria.

NetraGPT:Enhances NetraAI's Attractor technology with Large Language Models for added explainability and multidimensional patient profiling based on medical and scientific literature.

Specialties

Artificial Intelligence Clinical Trial Design Patient Stratification Placebo Response Analysis Quantum Machine Learning Attractor AI Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 3500000 MR: - FA: $3,500,000 FAN: 3500000	D: 2026-02-19 FD: 2026-02-19	1 investors
2	RT: Private Placement T: - FT: Private Placement	A: 3110000 MR: - FA: $3,110,000 FAN: 3110000	D: 2026-01-28 FD: 2026-01-28	1 investors
3	RT: Private Placement T: - FT: Private Placement	A: 3500000 MR: - FA: up to $3,500,000 CDN FAN: 3500000	D: 2026-01-13 FD: 2026-01-13	-
4	RT: Warrant Exercise T: - FT: Warrant Exercise	A: 1853054 MR: - FA: $1,853,054 FAN: 1853054	D: 2025-03-10 FD: 2025-03-10	-
5	RT: Warrant and Stock Option Exercise T: - FT: Warrant and Stock Option Exercise	A: 1161000 MR: - FA: $1,161,000 FAN: 1161000	D: 2024-12-12 FD: 2024-12-12	-
6	RT: Private Placement T: - FT: Private Placement	A: 242350 MR: - FA: $242,350 FAN: 242350	D: 2023-06-14 FD: 2023-06-14	-
7	RT: Private Placement T: - FT: Private Placement	A: 500000 MR: - FA: $500,000 FAN: 500000	D: 2023-06-09 FD: 2023-06-09	-
8	RT: Private Placement T: - FT: Private Placement	A: 250000 MR: - FA: up to $250,000 FAN: 250000	D: 2023-06-06 FD: 2023-06-06	-
9	RT: Private Placement T: - FT: Private Placement	A: 500000 MR: - FA: $500,000 FAN: 500000	D: 2023-06-01 FD: 2023-06-01	-
10	RT: Private Placement T: - FT: Private Placement	A: 733290 MR: - FA: $733,290 FAN: 733290	D: 2023-03-24 FD: 2023-03-24	-

Private Placement Latest

2026-02-19

$3.5M

1 investor (Pro only)

Private Placement 2026-01-28

$3.1M

Private Placement 2026-01-13

$3.5M

View 9 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Joseph Geraci

Founder, Chief Scientific and Technical Officer

S

Swanpan Kakumanu

Chief Financial Officer

M

Mike Tsay

Director of Bioinformatics

P

Paul Leonczyk

Scientist/Engineer

J

Jalal Ziauddin

Developer

G

George Achilleos

CEO

View 7 more team members with Pro

Unlock Full Team Directory

Recent News